Allopurinol
Product Images NDC 53808-0604

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 53808-0604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 100mg (Allopurinol 100mg(watson))

FDA Label Image

Label Image For 300mg (Allopurinol 300mg(watson))

Label Image For 300mg (Allopurinol 300mg(watson))
This is a description of a 300mg tablet of a medication called Allopurinol. The tablet is prescription-only and was produced by Watson Pharmaceuticals. The lot number of the tablet is TESZ001 TESB2048 and the expiry date is November 30, 2010. The tablet was packaged by the Department of Health Central Pharmacy in Tallahassee, Florida.*
FDA Label Image

Figure 1 (Allopurinol Figure 01)

FDA Label Image

Figure 2 (Allopurinol Figure 02)

Figure 2 (Allopurinol Figure 02)
This text appears to be a list of chemical compounds, including names such as Allopurinol, Oxipurinol, Xanthine, Uric Acid, Hypoxanthine, and 1,5-Dihydro-4H-pyrazolo- 1H-Pyrazolo[3,4-d]pyrimidine. It also includes some chemical formulas, such as [3.4-d)pyrimidin-4-one 4.6(5H,7H)-dione and purine-2,6-dione 2,6,8(3H)-trione, which suggest that these are related to pyrimidines and purines. Overall, this text likely pertains to the chemistry of these compounds and their structures.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.